|
Sign In to gain access to subscriptions and/or personal tools.
|
Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population
Scott B Patten
Department of Community Health Sciences, Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW Calgary, Alberta T2N 4N1, Canada, Department of Psychiatry, Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW Calgary, Alberta T2N 4N1, Canada, Alberta Heritage Foundation for Medical Research, 3125 Manulife Place, 10180 101 Street, Edmonton, Alberta, Canada, T5J 3S4
Luanne M Metz
Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, 12th Floor, 1403 29th Street N. W., Calgary Alberta, T2N 2T9, Canada
Marlene A Reimer
Faculty of Nursing, University of Calgary, 2500 University Drive N. W., Calgary, Alberta, T2N 1N4, Canada
The objective of this paper was to evaluate the lifetime and point prevalence of major depression in a population-based Multiple Sclerosis (MS) clinic sample, and to describe associations between selected biopsychosocial variables and the prevalence of lifetime major depression in this sample. Subjects who had participated in an earlier study were re-contacted for additional data collection. Eighty-three per cent (n=136) of those eligible consented to participate. Each subject completed the Composite International Diagnostic Interview (CIDI) and an interviewer-administered questionnaire evaluating a series of biopsychosocial variables. The lifetime prevalence of major depression in this sample was 22.8%, somewhat lower than previous estimates in MS clinic populations. Women, those under 35, and those with a family history of major depression had a higher prevalence. Also, subject reporting high levels of stress and heavy ingestion of caffeine (>400 mg) had a higher prevalence of major depression. As this was a cross-sectional analysis, the direction of causal effect for the observed associations could not be determined. By identifying variables that are associated with lifetime major depression, these data generate hypotheses for future prospective studies. Such studies will be needed to further understand the etiology of depressive disorders in MS.
Multiple Sclerosis, Vol. 6, No. 2,
115-120 (2000)
DOI: 10.1177/135245850000600210
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
G. Kraft, K. Johnson, K Yorkston, D Amtmann, A Bamer, C Bombardier, D Ehde, R Fraser, and H Starks
Setting the agenda for multiple sclerosis rehabilitation research
Multiple Sclerosis,
November 1, 2008;
14(9):
1292 - 1297.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Patten, J. Williams, and L. Metz
Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis
Multiple Sclerosis,
April 1, 2008;
14(3):
406 - 411.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Cetin, K.L. Johnson, D.M. Ehde, C.M. Kuehn, D. Amtmann, and G.H. Kraft
Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample
Multiple Sclerosis,
September 1, 2007;
13(8):
1046 - 1053.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K Gottberg, U Einarsson, S Fredrikson, L von Koch, and L W Holmqvist
A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence
J. Neurol. Neurosurg. Psychiatry,
January 1, 2007;
78(1):
60 - 65.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R F Brown, C C Tennant, S M Dunn, and J D Pollard
A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables
Multiple Sclerosis,
August 1, 2005;
11(4):
477 - 484.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Pandya, L. Metz, and S. B. Patten
Predictive Value of the CES-D in Detecting Depression Among Candidates for Disease-Modifying Multiple Sclerosis Treatment
Psychosomatics,
April 1, 2005;
46(2):
131 - 134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B Patten, G. Francis, L. M Metz, M. Lopez-Bresnahan, P. Chang, and F. Curtin
The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis
Multiple Sclerosis,
April 1, 2005;
11(2):
175 - 181.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. K. Zabad, S. B. Patten, and L. M. Metz
The association of depression with disease course in multiple sclerosis
Neurology,
January 25, 2005;
64(2):
359 - 360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Benedict, D. Cox, L. L Thompson, F. Foley, B. Weinstock-Guttman, and F. Munschauer
Reliable screening for neuropsychological impairment in multiple sclerosis
Multiple Sclerosis,
December 1, 2004;
10(6):
675 - 678.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Feinstein, P. Roy, N. Lobaugh, K. Feinstein, P. O'Connor, and S. Black
Structural brain abnormalities in multiple sclerosis patients with major depression
Neurology,
February 24, 2004;
62(4):
586 - 590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C H Bombardier, K D Blake, D M Ehde, L E Gibbons, D Moore, and G H Kraft
Alcohol and drug abuse among persons with multiple sclerosis
Multiple Sclerosis,
February 1, 2004;
10(1):
35 - 40.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. B. Patten, C. A. Beck, J. V.A. Williams, C. Barbui, and L. M. Metz
Major depression in multiple sclerosis: A population-based perspective
Neurology,
December 9, 2003;
61(11):
1524 - 1527.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B Patten, S. Fridhandler, C. A Beck, and L. M Metz
Depressive symptoms in a treated multiple sclerosis cohort
Multiple Sclerosis,
December 1, 2003;
9(6):
616 - 620.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. S. Ciccone and B. H. Natelson
Comorbid Illness in Women With Chronic Fatigue Syndrome: A Test of the Single Syndrome Hypothesis
Psychosom Med,
March 1, 2003;
65(2):
268 - 275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S P van der Werf, A Evers, P J. Jongen, and G Bleijenberg
The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis
Multiple Sclerosis,
February 1, 2003;
9(1):
89 - 94.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P Flachenecker, T Kumpfel, B Kallmann, M Gottschalk, O Grauer, P Rieckmann, C Trenkwalder, and K V Toyka
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters
Multiple Sclerosis,
December 1, 2002;
8(6):
523 - 526.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Chwastiak, D. M. Ehde, L. E. Gibbons, M. Sullivan, J. D. Bowen, and G. H. Kraft
Depressive Symptoms and Severity of Illness in Multiple Sclerosis: Epidemiologic Study of a Large Community Sample
Am J Psychiatry,
November 1, 2002;
159(11):
1862 - 1868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. FRIEDLANDER and M. E. MAHLER
Major depressive disorder: Psychopathology, medical management and dental implications
J Am Dent Assoc,
May 1, 2001;
132(5):
629 - 638.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
